BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Dermatomyositis |
📓
Genetically predicted the causal relationship between gut microbiota and the risk of polymyositis/dermatomyositis: a Mendelian randomization analysis. Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1409497 Pub: 2024 Epub: 2024 Aug 21 Authors Niu Y , Zhang Y , Fan K , Hou J , Liu L , Zhang H , Geng X , Ma X , Lin S , Guo M , Li X , Zhang S , Html Article Publication |
| Dermatomyositis |
📓
Staphylococcal infections in childhood dermatomyositis--association with the development of calcinosis, raised IgE concentrations and granulocyte chemotactic defect. Annals of the rheumatic diseases (Ann Rheum Dis ) Vol: 51 Issue 3 Pages: 378-83 Pub: 1992 Mar Epub: Authors Moore EC , Cohen F , Douglas SD , Gutta V , Html Article Publication |
| Dermatomyositis |
📓
Altered Gut Microbiome in Patients With Dermatomyositis. ACR open rheumatology (ACR Open Rheumatol ) Vol: Issue Pages: Pub: 2022 May 26 Epub: 2022 May 26 Authors Bae SS , Dong TS , Wang J , Lagishetty V , Katzka W , Jacobs JP , Charles-Schoeman C , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
